Vista Oncology

Olympia, Washington 98506

2 studies enrolling now · 6 studies all time

What they study most

Breast Cancer, Carcinoma, Non-Small-Cell Lung, Diffuse Large B Cell Lymphoma, Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer, Multiple Myeloma, Pancreatic Cancer

Studies at this site

• A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Recruiting now
• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
• A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer — Running, not enrolling
• Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients — Running, not enrolling
• Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients — Stopped early
• Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients — Completed